Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v2-FR
Language French French
Date Updated 2019-02-11 2018-05-10
Drug Identification Number 00318736 00318736
Brand name PROSTIN F2 ALPHA PROSTIN F2 ALPHA
Common or Proper name PROSTIN F2A PROSTIN F2A
Company Name PFIZER CANADA ULC PFIZER CANADA ULC
Ingredients DINOPROST DINOPROST
Strength(s) 5MG 5MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRA-AMNIOTIC INTRA-AMNIOTIC
Packaging size 1 x 1ml 1 x 1ml
ATC code G02AD G02AD
ATC description UTEROTONICS UTEROTONICS
Reason for discontinuation Other (Please describe in comments) Other (Please describe in comments)
Anticipated discontinuation date 2018-09-30
Actual discontinuation date 2018-09-30
Remaining supply date 2018-09-30 2018-09-30
Discontinuation status Discontinued To be discontinued
Discontinuation decision reversal no no
Information on remaining supply
Company comments The product discontinuation is due to low market demand. The product discontinuation is due to low market demand.
Health Canada comments